Regeneron Pharmaceuticals, Inc. (REGN)
781.49
-11.77
(-1.48%)
USD |
NASDAQ |
Sep 11, 16:00
782.62
+1.13
(+0.14%)
After-Hours: 07:15
Regeneron Pharmaceuticals Max Drawdown (5Y) : 59.69% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 59.69% |
| July 31, 2026 | 59.69% |
| June 30, 2026 | 59.69% |
| May 31, 2026 | 59.69% |
| April 30, 2026 | 59.69% |
| March 31, 2026 | 59.69% |
| February 28, 2026 | 59.69% |
| January 31, 2026 | 59.69% |
| December 31, 2025 | 59.69% |
| November 30, 2025 | 59.69% |
| October 31, 2025 | 59.69% |
| September 30, 2025 | 59.69% |
| August 31, 2025 | 59.69% |
| July 31, 2025 | 59.69% |
| June 30, 2025 | 59.69% |
| May 31, 2025 | 59.09% |
| April 30, 2025 | 54.48% |
| March 31, 2025 | 47.17% |
| February 28, 2025 | 44.76% |
| January 31, 2025 | 44.00% |
| December 31, 2024 | 43.25% |
| November 30, 2024 | 43.25% |
| October 31, 2024 | 47.49% |
| September 30, 2024 | 52.61% |
| August 31, 2024 | 53.84% |
| Date | Value |
|---|---|
| July 31, 2024 | 53.84% |
| June 30, 2024 | 53.84% |
| May 31, 2024 | 53.84% |
| April 30, 2024 | 53.84% |
| March 31, 2024 | 53.84% |
| February 29, 2024 | 53.84% |
| January 31, 2024 | 53.84% |
| December 31, 2023 | 53.84% |
| November 30, 2023 | 53.84% |
| October 31, 2023 | 53.84% |
| September 30, 2023 | 53.84% |
| August 31, 2023 | 53.84% |
| July 31, 2023 | 53.84% |
| June 30, 2023 | 53.84% |
| May 31, 2023 | 53.84% |
| April 30, 2023 | 53.84% |
| March 31, 2023 | 53.84% |
| February 28, 2023 | 53.84% |
| January 31, 2023 | 53.84% |
| December 31, 2022 | 53.84% |
| November 30, 2022 | 53.84% |
| October 31, 2022 | 53.84% |
| September 30, 2022 | 53.84% |
| August 31, 2022 | 53.84% |
| July 31, 2022 | 53.84% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| AbbVie, Inc. | 21.89% |
| Gilead Sciences, Inc. | 26.58% |
| Amgen, Inc. | 24.86% |
| Biogen, Inc. | 72.66% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -1.815 |
| Beta (5Y) | 0.1949 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 31.01% |
| Historical Sharpe Ratio (5Y) | -0.0015 |
| Historical Sortino (5Y) | -0.0024 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 14.09% |